SG Americas Securities’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-19,139
| Closed | -$641K | – | 3640 |
|
|
2026
Q1 | $641K | Sell |
19,139
-21,059
| -52% | -$826K | ﹤0.01% | 2038 |
|
|
2025
Q4 | $1.86M | Buy |
40,198
+25,412
| +172% | +$1.39M | ﹤0.01% | 1574 |
|
|
2025
Q3 | $1M | Buy |
+14,786
| New | +$1.1M | ﹤0.01% | 1460 |
|
|
2025
Q2 | – | Sell |
-4,397
| Closed | -$314K | – | 3529 |
|
|
2025
Q1 | $314K | Buy |
4,397
+350
| +9% | +$17K | ﹤0.01% | 2176 |
|
|
2024
Q4 | $182K | Sell |
4,047
-2,039
| -34% | -$106K | ﹤0.01% | 2243 |
|
|
2024
Q3 | $307K | Sell |
6,086
-7,855
| -56% | -$376K | ﹤0.01% | 2130 |
|
|
2024
Q2 | $569K | Buy |
+13,941
| New | +$591K | ﹤0.01% | 1606 |
|
|
2021
Q3 | – | Sell |
-19,938
| Closed | -$341K | – | 3893 |
|
|
2021
Q2 | $341K | Buy |
+19,938
| New | +$337K | ﹤0.01% | 2111 |
|
|
2020
Q3 | – | Sell |
-1,200
| Closed | -$40K | – | 3375 |
|
|
2020
Q2 | $40K | Buy |
+1,200
| New | +$52K | ﹤0.01% | 3569 |
|
SG Americas Securities's SLNO Position: Q2 2026 in Review
SG Americas Securities sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 19,139 shares — an estimated $641K sold.
SG Americas Securities first reported a position in SLNO in Q2 2020 and held it in 9 quarters. The position peaked at $1.86M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.
- SG Americas Securities reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
- SG Americas Securities sold 19,139 Soleno Therapeutics shares in Q2 2026, an estimated $641K.
- SG Americas Securities first reported a position in Soleno Therapeutics in Q2 2020 and held it in 9 quarters.
- SG Americas Securities's Soleno Therapeutics position peaked at $1.86M in Q4 2025.
- 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.